Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

TeleClinic vs WeightCare

TeleClinic
Graded #314

Higher grade

vs+2.1999999999999957
WeightCare
Graded #368

Lower grade

The verdict

TeleClinic takes it — 60.8/100 to 58.6/100.

TeleClinic grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. TeleClinic (Teleclinic Holdings LLC) is a US telehealth platform offering physician-prescribed compounded GLP-1 weight-loss medication — semaglutide and tirzepatide — shipped from a licensed 503A…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueTeleClinic +9
44
35
Dose & formulationTeleClinic +2
64
62
Clinical oversightWeightCare +7
80
87
Labs & monitoringWeightCare +2
52
54
FulfillmentTeleClinic +25
97
72
Contract termsWeightCare +21
20
41
TeleClinic · left barWeightCare · right bar

The numbers

MetricTeleClinicWeightCare
WeighScore60.8/10058.6/100
GradeCC
Scorecard rank#314#368
Semaglutide$199/mo (compounded)$399/mo
Tirzepatide$299/mo (compounded)$499/mo (15 mg dose, compounded)
Coverage47 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
TeleClinic

Graded #314 · C

Strengths

  • Names its pharmacy partner — Rush Pharmacy, a licensed 503A compounder — which many compounded-GLP-1 telehealths won't disclose
  • LegitScript certified with flat, published monthly pricing, free shipping, and no insurance required
  • Broad access: 47 states with US-licensed physicians and transparent cash-pay pricing

Where it loses points

  • Compounded semaglutide and tirzepatide only — no brand-name GLP-1 (Wegovy or Zepbound) option
  • Headline $139/$219 rates are first-quarter intro prices billed quarterly; ongoing month-to-month is $199/$299
  • Not available in California, South Carolina, or New Jersey
WeightCare

Graded #368 · C

Strengths

  • PCAB-accredited pharmacy partners — strongest pharmacy quality signal
  • Quality testing: potency and sterility per USP 797 standards
  • 85,000+ members since 2022 — established patient base
  • Multiple program tiers for semaglutide
  • Health coaching, dietitians, fitness trainers included

Where it loses points

  • No LegitScript certification on the site itself
  • State availability not explicitly listed
  • Compounded only — no brand-name options
  • Semaglutide runs $215-$399/mo and tirzepatide $275-$499/mo depending on plan length and dose

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard